DSM265
QP15C11
Phase 2 small_molecule terminated
Quick answer
DSM265 for Malaria is a Phase 2 program (small_molecule) at CNS Pharmaceuticals with 2 ClinicalTrials.gov record(s).
Program details
- Company
- CNS Pharmaceuticals
- Indication
- Malaria
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated